Expertise in
4
conditions

Pei-ning C. Wang

Yuanshan Branch, 
Yilan, TNQ, TW 
Expertise in
4
conditions
Yuanshan Branch, 
Yilan, TNQ, TW 

Overview

Pei-ning Wang practices practicing medicine in Yilan, Taiwan.

Wang is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Dementia, Developmental Dysphasia Familial, Memory Loss, and Alzheimer's Disease.

They are actively involved in clinical research, co-authoring 106 peer reviewed articles and participating in 2 clinical trials.

Locations

Yuanshan Branch, Yilan, TNQ, Taiwan
Other Locations
No. 201, Sec. 2 Shih Pai Rd, Taipei, TNQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Extension Study of a Phase IIa Study in Patients With Mild Alzheimer's Disease to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UBITh® AD Immunotherapeutic Vaccine (UB-311)
An Extension Study of a Phase IIa Study in Patients With Mild Alzheimer's Disease to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UBITh® AD Immunotherapeutic Vaccine (UB-311)
Enrollment Status: Terminated
Publish Date: January 26, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, 3-arm Parallel-group, Multicenter, Phase IIa Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UBITh® AD Immunotherapeutic Vaccine (UB-311) in Patients With Mild Alzheimer's Disease
A Randomized, Double-blind, Placebo-controlled, 3-arm Parallel-group, Multicenter, Phase IIa Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UBITh® AD Immunotherapeutic Vaccine (UB-311) in Patients With Mild Alzheimer's Disease
Enrollment Status: Completed
Publish Date: March 17, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 1 Less Clinical Trial

106 Total Publications

Validation of the VasCog-2-WSO VCID Criteria in a Dementia-Free and Stroke-Free Community Cohort: Cardiovascular Risk and Mortality.
Validation of the VasCog-2-WSO VCID Criteria in a Dementia-Free and Stroke-Free Community Cohort: Cardiovascular Risk and Mortality.
Journal: Neurology
Published: July 30, 2026

Frequently Asked Questions about Pei-ning C. Wang

Is Pei-ning C. Wang a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Pei-ning C. Wang is classified as an Advanced expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pei-ning C. Wang participate in research or clinical trials?

Yes. Pei-ning C. Wang has published 106 articles and abstracts on conditions like Dementia. You can view a list of Pei-ning C. Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wang's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile